Table 11.6b

Immunosuppression Used for Maintenance Prior to Discharge, 1994 to 2003

Recipients with Heart Transplants

		Year of Transplant
		1994	1995	1996	1997	1998	1999	2000	2001	2002	2003
Functioning Graft at Discharge		2,156	2,161	2,131	2,073	2,125	1,934	1,988	2,013	1,987	1,912
With Immunosuppression Info		2,152	2,112	1,850	2,054	2,115	1,924	1,980	1,988	1,974	1,859
Corticosteroids	Category Usage	96.2%	94.9%	96.3%	95.7%	96.0%	95.4%	94.3%	97.2%	96.8%	92.7%
	Steroids	96.2%	94.9%	96.3%	95.7%	96.0%	95.4%	94.3%	97.2%	96.8%	92.7%
Cyclosporine	Category Usage	94.8%	86.6%	81.8%	87.8%	85.7%	82.5%	80.3%	70.3%	60.1%	58.8%
	Cyclosporin	90.1%	71.4%	3.0%	0.0%	0.0%	0.1%	0.1%	0.1%	0.0%	0.0%
	Sandimmmune	4.7%	11.4%	22.5%	18.3%	16.6%	11.3%	8.1%	4.4%	2.8%	3.6%
	Neoral	0.5%	6.1%	59.5%	71.2%	72.2%	73.3%	72.3%	58.2%	45.1%	42.8%
	Gengraf	0.0%	0.0%	0.1%	0.0%	0.0%	0.0%	1.6%	8.5%	12.7%	14.3%
	Eon	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.2%	0.3%	0.1%
Tacrolimus	Category Usage	1.6%	4.3%	7.2%	9.9%	11.7%	14.1%	16.0%	30.1%	39.6%	41.3%
	FK506	1.6%	4.3%	7.2%	9.9%	11.7%	14.1%	16.0%	30.1%	39.6%	41.3%
Antimetabolites	Category Usage	95.5%	91.4%	91.9%	91.9%	92.2%	82.5%	88.0%	90.9%	84.1%	89.5%
	Azathioprine	93.6%	87.3%	79.0%	63.7%	49.9%	31.6%	19.4%	14.9%	12.2%	9.5%
	Mycophenolate mofetil	4.4%	5.8%	14.1%	31.5%	48.9%	53.9%	69.9%	78.5%	75.0%	82.4%
	Leflunomide	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.1%	0.0%
	Cytoxan	0.7%	1.3%	1.3%	1.5%	1.0%	0.5%	0.9%	0.5%	0.2%	0.2%
Other	Category Usage	0.0%	0.0%	0.0%	0.0%	0.1%	0.9%	2.6%	4.3%	9.9%	8.2%
	Rapamycin	0.0%	0.0%	0.0%	0.0%	0.1%	0.9%	2.6%	4.3%	9.9%	8.2%

Source: OPTN/SRTR Data as of May 3, 2004.

Individual drug percentages will not necessarily add up to the drug category percentages, as patients may

be prescribed more than one drug within the same category.